Market Cap: $1.63B
AI
Azenta, Inc.
AZTA
NASDAQ (NASDAQ Global Select)USD
Market Cap: $1.63B
Azenta, Inc. ( AZTA ) is drawing attention as the latest developments come into focus. Azenta, Inc. (AZTA) is at a pivotal junction as the company navigates through a landscape marked by operational c…
Azenta, Inc. ( AZTA ) is drawing attention as the latest developments come into focus. Azenta, Inc. (AZTA) is navigating a complex landscape marked by revenue declines and strategic shifts aimed at re…
Azenta, Inc. ( AZTA ) is at a pivotal crossroads as it navigates through a landscape marked by operational challenges and strategic transformations. The company, a key player in the biotechnology sect…
Azenta (Ticker: AZTA), a prominent player in the biotechnology industry, confronts a significant revenue decline as demand softens in North America. In its second quarter of 2026, the company reports…
Azenta Inc. announces the strategic appointment of Trey Martin as the president of its Multiomics business. This move aligns with the company's commitment to enhance its operational and growth strateg…
Azenta Expands Life Sciences Solutions with Acquisition of UK Biocentre Azenta, Inc., a leading player in life science solutions, announces the strategic acquisition of UK Biocentre Limited, a move th…
Azenta Expands Its Life Sciences Portfolio with Acquisition of UK Biocentre Azenta, Inc., a leader in life science solutions, makes a significant advancement in its operational capabilities by acquiri…
Azenta Expands Life Science Solutions with UK Biocentre Acquisition Azenta, Inc. solidifies its position in the life science sector with its acquisition of UK Biocentre Limited for GBP 20.5 million, a…
Azenta Showcases Commitment to Life Sciences at Upcoming Conference Azenta, Inc., a prominent player in life sciences solutions, announces its participation in the Raymond James 47th Annual Institutio…
Azenta Showcases Commitment to Life Sciences at Raymond James Conference Azenta, Inc., a prominent life sciences solutions provider, prepares for an impactful appearance at the Raymond James 47th Annu…
Azenta to Showcase Life Sciences Solutions at Upcoming Institutional Investor Conference In an effort to solidify its standing in the life sciences sector, Azenta, Inc. announces its participation in…
Azenta designates B Medical as discontinued as it pursues sale Azenta, a provider of sample management and multiomics services to the life‑sciences industry, is treating B Medical Systems as discontin…
Azenta treating B Medical as discontinued as sale nears close Strategic divestiture reshapes continuing operations Azenta, the life sciences sample management and multiomics company, is treating B Med…
B Medical divestiture reshapes Azenta’s operating profile Azenta reports that the results of B Medical Systems are treated as discontinued operations after the company announces a definitive agreement…
Azenta Repositions Focus Through Strategic Divestment Azenta, Inc., a prominent player in life sciences solutions, announces a significant strategic move with the sale of its B Medical Systems busines…
Strategic Realignment: Azenta Focuses on Core Capabilities Azenta, Inc. is taking decisive steps to refine its business portfolio by finalizing a binding agreement to sell its B Medical Systems busine…
Azenta Enhances Strategic Growth Through Share Repurchase Program Azenta, Inc., a key player in the life sciences sector, announces a substantial share repurchase program, authorized by its Board of D…
Azenta's Strategic Share Repurchase Program: A Commitment to Growth and Value Azenta, Inc., a leading player in the life sciences sector, announces a substantial share repurchase program aimed at bols…
Azenta's Strategic Share Repurchase Initiative: A Move Towards Long-Term Value Azenta, Inc. announces a strategic share repurchase program aimed at enhancing shareholder value and addressing its perce…
Navigating Economic Challenges: Azenta's Role in the Life Sciences Sector As companies across various sectors brace for upcoming earnings reports, Azenta, a leader in life sciences and laboratory auto…
Azenta Prepares for Key Earnings Report Amid Strategic Expansion As Azenta approaches its quarterly earnings report scheduled for November 21, 2025, the life sciences and laboratory services company i…
Azenta Prepares for Upcoming Earnings Report Amidst Market Anticipation Azenta, a prominent player in the life sciences and laboratory services sector, is set to release its quarterly earnings report…
Azenta Partners with PRECEDE Foundation to Combat Pancreatic Cancer Azenta, Inc. announces a significant strategic partnership with the PRECEDE Foundation, aimed at transforming the landscape of pancr…
Azenta Partners with PRECEDE Foundation to Combat Pancreatic Cancer Azenta, Inc. (Nasdaq: AZTA) announces a significant partnership with the PRECEDE Foundation, a leading global consortium focused on…
Azenta Partners with PRECEDE Foundation to Combat Pancreatic Cancer Azenta, Inc. has formed a significant strategic partnership with the PRECEDE Foundation, a global consortium focused on enhancing th…